Fujita J - Search Results

1

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.

Higashitsuji H, Higashitsuji H, Itoh K, Sakurai T, Nagao T, Sumitomo Y, Masuda T, Dawson S, Shimada Y, Mayer RJ, Fujita J. Higashitsuji H, et al. Among authors: fujita j. Cancer Cell. 2005 Jul;8(1):75-87. doi: 10.1016/j.ccr.2005.06.006. Cancer Cell. 2005. PMID: 16023600 Free article.

2

MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity.

Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, Mayer RJ, Itoh K, Fujita J. Nagao T, et al. Among authors: fujita j. J Biol Chem. 2003 Mar 21;278(12):10668-74. doi: 10.1074/jbc.M206104200. Epub 2003 Jan 13. J Biol Chem. 2003. PMID: 12525503 Free article.

3

A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells.

Sakurai T, Itoh K, Higashitsuji H, Nagao T, Nonoguchi K, Chiba T, Fujita J. Sakurai T, et al. Among authors: fujita j. J Biol Chem. 2004 Apr 9;279(15):15505-14. doi: 10.1074/jbc.M310437200. Epub 2004 Jan 22. J Biol Chem. 2004. PMID: 14739298 Free article.

4

The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.

Higashitsuji H, Liu Y, Mayer RJ, Fujita J. Higashitsuji H, et al. Among authors: fujita j. Cell Cycle. 2005 Oct;4(10):1335-7. doi: 10.4161/cc.4.10.2107. Epub 2005 Oct 17. Cell Cycle. 2005. PMID: 16177571

5

Gankyrin: a new oncoprotein and regulator of pRb and p53.

Dawson S, Higashitsuji H, Wilkinson AJ, Fujita J, Mayer RJ. Dawson S, et al. Among authors: fujita j. Trends Cell Biol. 2006 May;16(5):229-33. doi: 10.1016/j.tcb.2006.03.001. Epub 2006 Apr 3. Trends Cell Biol. 2006. PMID: 16581249

6

The oncoprotein gankyrin interacts with RelA and suppresses NF-kappaB activity.

Higashitsuji H, Higashitsuji H, Liu Y, Masuda T, Fujita T, Abdel-Aziz HI, Kongkham S, Dawson S, John Mayer R, Itoh Y, Sakurai T, Itoh K, Fujita J. Higashitsuji H, et al. Among authors: fujita j, fujita t. Biochem Biophys Res Commun. 2007 Nov 23;363(3):879-84. doi: 10.1016/j.bbrc.2007.09.072. Epub 2007 Sep 29. Biochem Biophys Res Commun. 2007. PMID: 17904523

7

Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.

Ortiz CM, Ito T, Tanaka E, Tsunoda S, Nagayama S, Sakai Y, Higashitsuji H, Fujita J, Shimada Y. Ortiz CM, et al. Among authors: fujita j. Int J Cancer. 2008 Jan 15;122(2):325-32. doi: 10.1002/ijc.23106. Int J Cancer. 2008. PMID: 17935131

8

The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy.

Fujita J, Sakurai T. Fujita J, et al. Adv Exp Med Biol. 2019;1164:63-71. doi: 10.1007/978-3-030-22254-3_5. Adv Exp Med Biol. 2019. PMID: 31576540

9

A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis.

Higashitsuji H, Higashitsuji H, Nagao T, Nonoguchi K, Fujii S, Itoh K, Fujita J. Higashitsuji H, et al. Among authors: fujita j. Cancer Cell. 2002 Oct;2(4):335-46. doi: 10.1016/s1535-6108(02)00152-6. Cancer Cell. 2002. PMID: 12398897 Free article.

10

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.

Higashitsuji H, Itoh K, Nagao T, Dawson S, Nonoguchi K, Kido T, Mayer RJ, Arii S, Fujita J. Higashitsuji H, et al. Among authors: fujita j. Nat Med. 2000 Jan;6(1):96-9. doi: 10.1038/71600. Nat Med. 2000. PMID: 10613832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,389 results

Search Page

Filters